ProQR Therapeutics (PRQR) Shares Outstanding (2021 - 2025)

ProQR Therapeutics (PRQR) has disclosed Shares Outstanding for 5 consecutive years, with $122.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 9.09% to $122.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $122.6 million through Dec 2025, up 9.09% year-over-year, with the annual reading at $122.6 million for FY2025, 9.09% up from the prior year.
  • Shares Outstanding hit $122.6 million in Q4 2025 for ProQR Therapeutics, up from $112.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $122.6 million in Q4 2025 to a low of $81.6 million in Q4 2021.
  • Historically, Shares Outstanding has averaged $97.3 million across 5 years, with a median of $87.5 million in 2023.
  • Biggest five-year swings in Shares Outstanding: rose 1.1% in 2022 and later grew 28.44% in 2024.
  • Year by year, Shares Outstanding stood at $81.6 million in 2021, then grew by 1.1% to $82.5 million in 2022, then grew by 6.16% to $87.5 million in 2023, then grew by 28.44% to $112.4 million in 2024, then grew by 9.09% to $122.6 million in 2025.
  • Business Quant data shows Shares Outstanding for PRQR at $122.6 million in Q4 2025, $112.4 million in Q4 2024, and $87.5 million in Q4 2023.